Nicole Grogan Fleege, MD(@NicoleFleege) 's Twitter Profileg
Nicole Grogan Fleege, MD

@NicoleFleege

Breast oncologist @uihealthcare. Supportive oncology research. Alum @uiowa @iowamed @IntMedatIowa @IM_iowa @UMHemOncFellows.

ID:1308960486810148864

calendar_today24-09-2020 02:44:50

596 Tweets

669 Followers

194 Following

Nicole Grogan Fleege, MD(@NicoleFleege) 's Twitter Profile Photo

I’m both sad that it’s over & grateful that I got to watch it happen.

I can’t wait to tell my daughter all about you, Caitlin Clark! Thank you for making Iowa so, so proud. You being a will always be one of our favorite things.

Iowa Women's Basketball University of Iowa

I’m both sad that it’s over & grateful that I got to watch it happen. I can’t wait to tell my daughter all about you, @CaitlinClark22! Thank you for making Iowa so, so proud. You being a #Hawkeye will always be one of our favorite things. #CaitlinClark #WBB @IowaWBB @uiowa
account_circle
Dr Sarah Sammons(@drsarahsam) 's Twitter Profile Photo

Hot tumor board topic! How do we tailor adjuvant therapy without ax dissection?

✔️Pts w 2+ SLNs, 51.3% had more nodes on dissection

In 2485 pts nodal status =
N1: 99.5% SLN group v 87% ax dissection
N2: 0.5% SLN group v 10% ax dissection N3: 3.0% ax dissection

account_circle
Ryan Nipp, MD, MPH(@RyanNipp) 's Twitter Profile Photo

Impact of Broadening Trial Eligibility Criteria on the Inclusion of Patients With Brain Metastases in Clinical Trials: Time Series Analyses for 2012-2022.

ascopubs.org/doi/abs/10.120…

ASCO Journal of Clinical Oncology JCO Oncology Practice
Research
Dawn Hershman DrJoeUnger

Impact of Broadening Trial Eligibility Criteria on the Inclusion of Patients With Brain Metastases in #Cancer Clinical Trials: Time Series Analyses for 2012-2022. ascopubs.org/doi/abs/10.120… @ASCO @JCO_ASCO @JCOOP_ASCO #ClinicalTrials #CancerResearch @DrDawnHershman @DrJoeUnger
account_circle
Paolo Tarantino(@PTarantinoMD) 's Twitter Profile Photo

So proud to see the diffusion of our review on ADC toxicities, with already 25k accesses and >300 Altmetric! The article will be made free to access and download in the days surrounding , starting today: download a copy if you have interest in ADCs! nature.com/articles/s4157…

So proud to see the diffusion of our review on ADC toxicities, with already 25k accesses and >300 Altmetric! The article will be made free to access and download in the days surrounding #AACR24, starting today: download a copy if you have interest in ADCs! nature.com/articles/s4157…
account_circle